FDA warns of eye infection from repackaged Avastin

08/30/2011 | New York Times (tiered subscription model), The

In a public alert, the FDA reported at least 12 cases of serious eye infection in Florida patients treated with Genentech's injectable drug Avastin that was repackaged at a pharmacy. Meanwhile, a Tennessee newspaper reported that four patients were given shots with bacterial contamination. Avastin is approved to treat cancer but is used off-label to treat wet age-related macular degeneration.

View Full Article in:

New York Times (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
White Plains, NY
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ